Showing results (1071-1080 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|March 1, 1989
Sustained release properties of the once daily theophylline capsule BY912 as compared with Theo-24 capsulesJ H Jonkman, V W Steinijans, W Beier, et al.Biopharmaceutics & Drug Disposition|June 4, 2015
PBPK modeling of irbesartan: incorporation of hepatic uptakeHelene Chapy, Sylvie Klieber, Priscilla Brun, et al.Biopharmaceutics & Drug Disposition|July 1, 1982
Buccal uptake, urinary excretion, and physicochemical properties of zipeprol and its N-dealkylated productsR Achari, A H BeckettBiopharmaceutics & Drug Disposition|July 1, 1982
Effect of sustained release on the pharmacokinetic profile of indomethacin in manK C Yeh, E T Berger, G O Breault, et al.Biopharmaceutics & Drug Disposition|July 1, 1982
Disposition of cyclophosphamide in the rabbit and human corneaR D Schoenwald, J A HousemanBiopharmaceutics & Drug Disposition|April 1, 1981
Platinum levels in human erythrocytes following intravenous administration of cisplatin: importance of erythrocytes as a distribution site for platinum speciesD F Long, T F Patton, A J ReptaBiopharmaceutics & Drug Disposition|November 18, 2025
Across-Species Meta-Analysis of Betamethasone Pharmacokinetics Utilizing a Minimal PBPK ModelCongyu Zhang, William J JuskoBiopharmaceutics & Drug Disposition|January 2, 2021
Selective inhibitory effects of HYIpro-3-1 on CYP1A2 in human liver microsomesYounah Kim, Ju-Hyun Kim, Taeho Lee, et al.Biopharmaceutics & Drug Disposition|January 12, 2020
Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactionsJaana Rytkönen, Veli-Pekka Ranta, Merja Kokki, et al.Biopharmaceutics & Drug Disposition|November 22, 2022
Predicting transporter mediated drug-drug interactions via static and dynamic physiologically based pharmacokinetic modeling: A comprehensive insight on where we are now and the way forwardGautam Vijaywargi, Sivacharan Kollipara, Tausif Ahmed, et al.Pageof 214